Stock Screener App

Frei -

Installieren

2.04

1.49% 0.03

Aytu Biopharma Inc (AYTU)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Aytu Biopharma Inc-Aktie (AYTU)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	29.77% 16.11	12.41	15.16	13.89	15.13
Cost Of Revenue	18.39% 5.697	4.812	5.541	4.702	4.881
Gross Profit	36.98% 10.41	7.599	9.624	9.186	10.25
Operating Expenses	4.09% 11.19	11.66	11.59	10.69	17.88
Operating Income/Loss	80.88% -0.777	-4.064	-1.97	-1.504	-7.623
Income/Loss From Continuing Operations Before Tax	99.93% -0.004	-5.608	-10.58	1.965	-19.44
Income Tax Expense/Benefit	10.00% 0.011	0.01	-	-	0.437
Income/Loss From Continuing Operations After Tax	99.73% -0.015	-5.618	-10.58	1.965	-19.88
Income/Loss From Discontinued Operations, Net Of Tax	-	-	-	-	0.062
Net Income/Loss	99.73% -0.015	-5.618	-10.58	1.965	-19.82

TXMD

$1.90

1.55%

SHPH

$5.08

8.80%

UPC

$3.93

5.30%

OPTH

$3.38

5.96%

RMTI

$7.43

6.89%

CPHI

$0.7099

2.47%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters